Targeting viruses and bacteria

S. L. Johnston (London, United Kingdom)

Source: Annual Congress 2007 - Novel therapies for severe asthma
Session: Novel therapies for severe asthma
Session type: Symposium
Number: 368
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. L. Johnston (London, United Kingdom). Targeting viruses and bacteria. Annual Congress 2007 - Novel therapies for severe asthma

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Epidemiology and biology of the common respiratory viruses, atypical bacteria, and bacteria
Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation
Year: 2004

The role of bacteria and viruses in lung disease
Source: International Congress 2016 – Diseases and defences of the respiratory mucosa
Year: 2016

The role of viruses and other atypical bacteria in bronchiectasis‘ exacerbations
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Broccoli sprout homogenates and live attenuated influenza virus: Effect on peripheral blood natural kill cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015

IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013

Cationic host defence peptides as a novel treatment for respiratory viral infections
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018

An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015

Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

The role of viruses in CAP
Source: Eur Respir Monogr 2014; 63: 74-87
Year: 2014

Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020

Biomarkers of bacterial infection
Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful?
Year: 2008

Bronchiectasies. Colonisation with potential pathogenic bacteria in stable clinical conditions
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

Viruses and bacteria in paediatric asthma
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016

The ancient rubredoxin system: An efficient defense mechanism of pseudomonas aeruginosa during infections
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014

From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020